Inventor · disambiguated record
Simon M. Ametamey
Also filed as: AMETAMEY SIMON · AMETAMEY SIMON M · AMETAMEY SIMON MENSAH
7 granted patents·7 pending applications·14 citations·filing 2004–2024
73Inventor score
Top patents by PatentIndex Score
14 records- 0181US8557776B2Compounds and methods for 18F labeled agentsLEHMANN LUTZ·Filed 2007·Granted Oct 15, 2013·14 cites·23 claims
- 0271US2024383872A1Novel pyridine and pyrazine compounds as inhibitors of cannabinoid receptor 2HOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 0365US12071420B2Pyridine and pyrazine compounds as inhibitors of cannabinoid receptor 2HOFFMANN LA ROCHE·Filed 2020·Granted Aug 27, 2024·0 cites·18 claims
- 0464US11999710B2Radiolabeled cannabinoid receptor 2 ligandHOFFMANN LA ROCHE·Filed 2020·Granted Jun 4, 2024·0 cites·23 claims
- 0563US2024308974A1Radiolabeled cannabinoid receptor 2 ligandHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 0657US12180196B2Azetidine-substituted pyridine and pyrazine compounds as inhibitors of cannabinoid receptor 2HOFFMANN LA ROCHE·Filed 2020·Granted Dec 31, 2024·0 cites·10 claims
- 0749US11655243B2Pyridine and pyrazine derivatives as preferential cannabinoid 2 agonistsHOFFMANN LA ROCHE·Filed 2020·Granted May 23, 2023·0 cites·16 claims
- 0848US2022118118A1Benzazepin-l,7-diol-derived radiolabeled ligands with high in vivo nmda specificityETH ZUERICH·Filed 2019·Application pending·0 cites
- 0944US8674110B2Pyridylacetylenes for use as radiotracers and imaging agentsGASPARINI FABRIZIO·Filed 2004·Granted Mar 18, 2014·0 cites·2 claims
- 1042US2014142318A1Pyridylacetylenes for use as radiotracers and imaging agentsGASPARINI FABRIZIO·Filed 2014·Application pending·0 cites
- 1141US10227308B2Radiolabeled cannabinoid receptor 2 ligandHOFFMANN LA ROCHE·Filed 2017·Granted Mar 12, 2019·0 cites·8 claims
- 1239US2009035215A1RadiofluorinationSRINIVASAN ANANTH·Filed 2007·Application pending·0 cites
- 1331US2017224852A1Benzazepin-1-ol-derived pet ligands with high in vivo nmda specificityETH ZUERICH·Filed 2017·Application pending·0 cites
- 1423US2017174632A14-oxo-1, 4-dihydroquinoline-3-carboxamide as selective ligand for cannabinoid receptor 2 for diagnosis and therapyETH ZUERICH·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →